NCT03494855

Evaluating the Efficacy of SyMRI in Clinical Pediatric Populations

Reducing Scan Times and Improving Care Through Quantitative Imaging: Evaluating the Efficacy of SyMRI in Clinical Pediatric Populations

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 5 (actual)
• Sponsor: The Hospital for Sick Children · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Accepted

Summary

Synthetic MR Technologies has created a quantified imaging solution - SyMRI - to enable radiologists to acquire quantified images and always obtain the best contrast images. This study represents an attempt to assess the clinical utility of this software.

Detailed description

Typical magnetic resonance imaging (MRI) involves taking many images called 'contrasts' to look at the body in different ways. Standard scan settings are usually good enough for a radiologist to review. The best settings often change with the age of the patient and their health, and are time consuming to determine. Quantified imaging is an alternative to contrast-based imaging which explicitly measures tissue properties and can be used to create almost any contrast. This method of imaging has been held back by a lack of the right software. Synthetic MR Technologies has created a quantified imaging solution - SyMRI - to enable radiologists to acquire quantified images and always obtain the best contrast images. The objective of this study is to evaluate SyMRI in a pediatric population to determine if Sickkids would be interested in purchasing this product / support Health Canada approval. Specifically, the investigators are interested in determining if SyMRI is clinically useful: * Is synthetic imaging quality comparable / better than conventional imaging? * Qualitative - Are radiologists more confident using synthetic MR vs conventional * Quantitative - Signal-to-noise (SNR) and Contrast-to-noise (CNR) * To what extent can total exam times be reduced? * Is the software user friendly and would investigators use it?

Conditions

• Brain Injuries
• Brain Development Abnormality
• Brain Pathology

Interventions

Type	Name	Description
DEVICE	SyMRI Software	The MDME sequence aims to provide whole absolute quantification of T1, T2, PD and B1 inhomogeneity in 5 minutes at typical clinical resolution (0.8 x 0.8 x 5mm). SyMRI software then allows a user to synthesize any almost image contrast (T1, T2, PD, FLAIR, IR, DIR, etc) by adjusting imaging parameters after the fact.

Timeline

• Start date: 2016-06-01
• Primary completion: 2018-08-22
• Completion: 2019-01-01
• First posted: 2018-04-11
• Last updated: 2019-07-16

Locations

1 site across 1 country: Canada